相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial
Stefan H. Hohnloser et al.
EUROPACE (2016)
XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
A. John Camm et al.
EUROPEAN HEART JOURNAL (2016)
Patient Satisfaction With Warfarin- and Non–Warfarin-Containing Thromboprophylaxis Regimens for Atrial Fibrillation
Craig I. Coleman et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban
Sally Tamayo et al.
CLINICAL CARDIOLOGY (2015)
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial
Martin H. Prins et al.
THROMBOSIS RESEARCH (2015)
Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non-Valvular Atrial Fibrillation
Moti Haim et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Psychological effects of treatment with new oral anticoagulants in elderly patients with atrial fibrillation: a preliminary report
Stefano Fumagalli et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2015)
Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
Irene Savelieva et al.
CLINICAL CARDIOLOGY (2014)
Patient perspective on the management of atrial fibrillation in five European countries
Ameet Bakhai et al.
BMC CARDIOVASCULAR DISORDERS (2013)
Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
Ajay K. Kakkar et al.
PLOS ONE (2013)
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis
Luke Bamber et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Oral Anticoagulant Therapy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Walter Ageno et al.
CHEST (2012)
Effect of dosing frequency on chronic cardiovascular disease medication adherence
Craig I. Coleman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients
Stefan J. Cano et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2012)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
Robert G. Hart et al.
ANNALS OF INTERNAL MEDICINE (2007)
Methods to explain the clinical significance of health status measures
GH Guyatt et al.
MAYO CLINIC PROCEEDINGS (2002)
分享论文
